Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NExT Study: Injection-Free Regimen for MDR-TB
NCT02454205Phase 3Completed
- Sponsor
- University of Cape Town
- Start
- Nov 2015
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bedaquiline, linezolid, levofloxacin in multidrug-resistant tuberculosis (MDR-TB), sponsored by University of Cape Town. Started Nov 2015; status: completed.
02
Drugs
bedaquilinelinezolidlevofloxacin
03
Conditions
multidrug-resistant tuberculosis (MDR-TB)
Beyond the preview
Go deeper on NCT02454205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02454205.